Inden Pharma, a Spanish packaging company, has partnered with ALPLApharma, an Austrian company that specialises in plastic packaging for pharmaceuticals, to expand into India. 

 

The firms have signed an agreement for the certified manufacturing of bottles, containers and closures in clean rooms, beginning in March, in an effort to strengthen their presence in the global market for pharmaceutical packaging. By 2023, the companies expect to produce 800 million pharmaceutical packaging items annually, a three-fold increase over the next five years.  

 

The standard items provided by Inden Pharma will be incorporated into the combined ALPLApharma and Inden Pharma product catalogue, bringing the total number of items available to more than 150.“Our international customers benefit from a greater variety of plants, proximity, high flexibility as well as the service and quality in deliveries that has been routine throughout the last few years,” stated Juan Guillem Gonzalez, the owner and CEO of Inden Pharma.

 

With Inden Pharma's two facilities in Spain and another one of  the two businesses are jointly constructing in Germany, the agreement also includes production sites from ALPLApharma in Greece and Poland.

 

To reach 30.5 million euros in sales in 2022, Inden Pharma has tripled its sales over the last four years. More than 550 million containers are sold by Inden Pharma every year throughout 35 nations and 5 continents. ALPLA has consistently grown into new nations, technologies and product categories since entering the quickly expanding pharmaceutical packaging sector in 2016.

 

The pharmaceutical packaging market in India is expanding quickly. According to market research firm Mordor Intelligence, the pharmaceutical packaging industry in India is predicted to expand at an annualised rate of 6.8% between 2021 and 2026.